“Duvyzat (Givinostat) in Duchenne Muscular Dystrophy: Mechanisms, Clinical Impact, and Future Directions”. 2025. Current Pharmaceutical Research 1 (3): 308-22. https://doi.org/10.63785/cpr.2025.1.3.308322.